Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by HighteawithIntrepidon May 22, 2018 7:04pm
320 Views
Post# 28066433

RE:RE:Buyout

RE:RE:BuyoutOur lack of cash has us in the financial discount bin. However, I believe that 
PL considers PLI his baby and any deal would involve keeping him on board.
It is obvious that the FDA delay rests with PL thinking that people that tick boxes 
would over look a missing box because of our great science. So I see 90% FUBAR 
and 10% Trump’s made in America filtering in perhaps at the behest of US Corporate 
Pharma. But in greater scheme of things we aren’t on Bloomberg radar screen.
Bullboard Posts